Kategorien
-
Adhesives
5
Amines
92
Amino Acids
179
Analytical Reagents
668
Antibiotics
247
Bioactive Small Molecules
716
Aroma Chemicals
203
Biochemicals
1004
Boronic Acids
4
Buffers
96
Building Blocks
1759
Carbohydrates
176
Catalysts
96
Chiral Compounds
53
Coccus nucifera oil
0
Detergents
57
Diagnostic Raw Materials
257
Flavours and Fragrance Materials
202
Fluorinated Products
43
Furans
5
Gases in Solution
47
Grignard Reagents
18
HPLC Reagents
8
Imidazoles
17
Indoles
41
Inorganic Chemicals
321
Ion-Pair Reagents
24
Ligands
79
Organics
1295
Oxazoles
3
Peptide Reagents
90
Phenols
45
Picolines
0
Piperazines
10
Pyrazines
2
Pyridines
54
Pyrimidines
30
Quaternary Ammonium salts
42
Reagents
97
Research Organics & Inorganics
753
Salts
281
Sealing Compounds
1
Sherclin
1
Solvents
121
Stains & Indicators
292
Sugars
63
Tailor-made solutions
1
Testing Standards
4
Uncategorised
90
Water Analysis
12
Alizarin (C.I. 58000)
(29169958 | 72-48-0)
CAS: | 72-48-0 |
---|---|
Molekularformel: | C14H8O4 |
Molekulargewicht: | 240.21 |
Verfügbarkeit: | Auf Lager |
---|---|
Downloads: | | |
Für dieses Produkt wird ein Gefahrstoffzuschlag erhoben. Der genaue Betrag wird von unserem Verkaufsteam bestätigt.
29169958-100g | 100g | £42.60 | |
Bulk Menge |
29169958-100g | 100g | €59.70 | |
Bulk Menge |
29169958-100g | 100g | $63.90 | |
Bulk Menge |
Sicherheitsdatenblatt
Analysezertifikat
Produktbeschreibung
Product Code | 29169958 | ||||
Product Name | Alizarin (C.I. 58000) | ||||
Categories | Stains & Indicators | ||||
CAS | 72-48-0 | ||||
Molecular Formula | C14H8O4 | ||||
Molecular Weight | 240.21 | ||||
Storage Details | Ambient | ||||
Harmonised Tariff Code | 32129000 |
Produktspezifikation
Grade | Industrial | ||||
Molecular Weight | 240.213 | ||||
Appearance | Brown to orange/ yellow powder | ||||
Ignition residue | 2.0% max | ||||
Indicator | pH 5.8 to 7.2 | ||||
For research use only, not for human use | research use only, not for human use |
Sicherheitsinformation
Pictograms |
|
||||
Signal word | danger | ||||
Hazard statements |
|
||||
Precautionary statements |
|